Alan Nurden: Honoring the Legacy of Dr. Richard Aster
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared Versiti Blood Research Institute’s post on LinkedIn, adding:
“This is very sad news indeed.
Richard Aster was a true pioneer for platelet immunology making valuable contributions all along an outstanding career.
I first met with him in 1980 when he visited Paris to see Tom Kunicki who was performing post-doctoral studies in my group.
Prior to this, Richard Aster and Tom had established that the major platelet receptors were targets for certain drug-dependent antibodies.
Richard’s contribution towards establishing the Blood Center in Milwaukee as a world-leading center for platelet research was enormous and his legacy is shown by the quality of the large number of researchers/clinicians who he trained and mentored.
Never forgetting to orientate his research towards blood transfusion and the clinic, Richard was one of the greats of our field. He will be sorely missed.”
Versiti Blood Research Institute shared a post on LinkedIn:
“Today we remember Richard Herbert ‘Dick’ Aster, whose life and work helped shape modern blood medicine and the future of blood health research.
Dr. Aster joined the Milwaukee Blood Center, now Versiti, in 1970 and later served as president and CEO.
Over the decades that followed, he helped build the scientific, clinical and organizational foundations that continue to support patients, hospitals, researchers and communities today.
A physician, scientist, mentor and teacher, Aster believed research and patient care should advance together.
His work transformed understanding of immune platelet disorders and influenced generations of physicians and scientists in hematology and transfusion medicine.
Those who knew him often speak first about his humility, intellectual curiosity and steady leadership.
His impact continues through the science he advanced, the people he mentored and the mission he helped strengthen.
We extend our deepest sympathies to his wife, Sara ‘Patsy,’ his family, friends and colleagues across the scientific and medical communities.
Read more about his legacy.”
Find more posts featuring Alan Nurden and Versiti Blood Research Institute on Hemostasis Today.
-
Jun 6, 2026, 14:17Danny Hsu: A Practice-Changing Milestone in Managing Post-Thrombotic Syndrome
-
Jun 6, 2026, 13:01Kathleen Freson: αIIbβ3’s Hidden Role in Platelet Production
-
Jun 6, 2026, 12:22Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
-
Jun 6, 2026, 12:06Reza Shojaei: Why Dried Plasma May Be the Most Important Plasma Innovation in Decades
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI